Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Cromwell

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biologicals : Journal of the International Association of Biological Standardization|July 28, 2016
Integration of QbD risk assessment tools and overall risk managementBrian Kelley, Mary Cromwell, Joe Jerkins
The AAPS Journal|May 14, 2008
Concluding summary: proceedings of the AAPS Biotec open forum on "aggregation of protein therapeutics"Steven J Shire, Mary Cromwell, Jun Liu
Journal of Pharmaceutical Sciences|September 2, 2014
Effect of individual Fc methionine oxidation on FcRn binding: Met252 oxidation impairs FcRn binding more profoundly than Met428 oxidationXuan Gao, Junyan A Ji, Karthik Veeravalli, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 20, 2016
Establishing a control system using QbD principlesJ Felix Kepert, Mary Cromwell, Niklas Engler, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 20, 2015
In-use physicochemical and microbiological stability of biological parenteral productsMargaret Speed Ricci, Michelle Frazier, Jamie Moore, et al.
Journal of Pharmaceutical Sciences|March 24, 2010
An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeuticsSatish K Singh, Nataliya Afonina, Michel Awwad, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biologicals : Journal of the International Association of Biological Standardization|July 28, 2016
Integration of QbD risk assessment tools and overall risk managementBrian Kelley, Mary Cromwell, Joe Jerkins
The AAPS Journal|May 14, 2008
Concluding summary: proceedings of the AAPS Biotec open forum on "aggregation of protein therapeutics"Steven J Shire, Mary Cromwell, Jun Liu
Journal of Pharmaceutical Sciences|September 2, 2014
Effect of individual Fc methionine oxidation on FcRn binding: Met252 oxidation impairs FcRn binding more profoundly than Met428 oxidationXuan Gao, Junyan A Ji, Karthik Veeravalli, et al.
Biologicals : Journal of the International Association of Biological Standardization|July 20, 2016
Establishing a control system using QbD principlesJ Felix Kepert, Mary Cromwell, Niklas Engler, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 20, 2015
In-use physicochemical and microbiological stability of biological parenteral productsMargaret Speed Ricci, Michelle Frazier, Jamie Moore, et al.
Journal of Pharmaceutical Sciences|March 24, 2010
An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeuticsSatish K Singh, Nataliya Afonina, Michel Awwad, et al.
Pageof 1